nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.51	1	CbGbCtD
Lamivudine—PGK1—hindbrain—amyotrophic lateral sclerosis	0.0106	0.0889	CbGeAlD
Lamivudine—Fungal skin infection—Riluzole—amyotrophic lateral sclerosis	0.00689	0.038	CcSEcCtD
Lamivudine—PGK1—brainstem—amyotrophic lateral sclerosis	0.00609	0.051	CbGeAlD
Lamivudine—CMPK1—hindbrain—amyotrophic lateral sclerosis	0.00542	0.0454	CbGeAlD
Lamivudine—NME2—hindbrain—amyotrophic lateral sclerosis	0.0053	0.0444	CbGeAlD
Lamivudine—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00507	0.028	CcSEcCtD
Lamivudine—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00507	0.028	CcSEcCtD
Lamivudine—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00489	0.027	CcSEcCtD
Lamivudine—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00453	0.025	CcSEcCtD
Lamivudine—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00418	0.0231	CcSEcCtD
Lamivudine—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00372	0.0206	CcSEcCtD
Lamivudine—PCYT2—nervous system—amyotrophic lateral sclerosis	0.00371	0.0311	CbGeAlD
Lamivudine—PCYT2—central nervous system—amyotrophic lateral sclerosis	0.00357	0.0299	CbGeAlD
Lamivudine—NME2—embryo—amyotrophic lateral sclerosis	0.00332	0.0278	CbGeAlD
Lamivudine—PGK1—nervous system—amyotrophic lateral sclerosis	0.00319	0.0267	CbGeAlD
Lamivudine—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00318	0.0176	CcSEcCtD
Lamivudine—CMPK1—brainstem—amyotrophic lateral sclerosis	0.00311	0.026	CbGeAlD
Lamivudine—PGK1—central nervous system—amyotrophic lateral sclerosis	0.00307	0.0257	CbGeAlD
Lamivudine—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00304	0.0168	CcSEcCtD
Lamivudine—NME2—brainstem—amyotrophic lateral sclerosis	0.00304	0.0254	CbGeAlD
Lamivudine—PGK1—cerebellum—amyotrophic lateral sclerosis	0.003	0.0251	CbGeAlD
Lamivudine—SLC22A3—tongue—amyotrophic lateral sclerosis	0.00287	0.024	CbGeAlD
Lamivudine—PCYT2—brain—amyotrophic lateral sclerosis	0.00284	0.0238	CbGeAlD
Lamivudine—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.0027	0.0149	CcSEcCtD
Lamivudine—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0027	0.0149	CcSEcCtD
Lamivudine—NT5C—nervous system—amyotrophic lateral sclerosis	0.00269	0.0225	CbGeAlD
Lamivudine—NT5C—central nervous system—amyotrophic lateral sclerosis	0.00259	0.0217	CbGeAlD
Lamivudine—NT5C—cerebellum—amyotrophic lateral sclerosis	0.00253	0.0212	CbGeAlD
Lamivudine—PCYT1A—nervous system—amyotrophic lateral sclerosis	0.00253	0.0212	CbGeAlD
Lamivudine—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.0025	0.0138	CcSEcCtD
Lamivudine—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00245	0.0135	CcSEcCtD
Lamivudine—PGK1—brain—amyotrophic lateral sclerosis	0.00244	0.0204	CbGeAlD
Lamivudine—PCYT1A—central nervous system—amyotrophic lateral sclerosis	0.00243	0.0204	CbGeAlD
Lamivudine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00242	0.0134	CcSEcCtD
Lamivudine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00233	0.0129	CcSEcCtD
Lamivudine—Injury—Riluzole—amyotrophic lateral sclerosis	0.00227	0.0125	CcSEcCtD
Lamivudine—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00219	0.0121	CcSEcCtD
Lamivudine—NT5C—brain—amyotrophic lateral sclerosis	0.00206	0.0172	CbGeAlD
Lamivudine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00206	0.0113	CcSEcCtD
Lamivudine—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00206	0.0113	CcSEcCtD
Lamivudine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00198	0.0109	CcSEcCtD
Lamivudine—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00194	0.0107	CcSEcCtD
Lamivudine—CMPK1—spinal cord—amyotrophic lateral sclerosis	0.00193	0.0162	CbGeAlD
Lamivudine—PCYT1A—brain—amyotrophic lateral sclerosis	0.00193	0.0162	CbGeAlD
Lamivudine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00193	0.0106	CcSEcCtD
Lamivudine—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0104	CcSEcCtD
Lamivudine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00184	0.0102	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00184	0.0102	CcSEcCtD
Lamivudine—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00182	0.01	CcSEcCtD
Lamivudine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00996	CcSEcCtD
Lamivudine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00996	CcSEcCtD
Lamivudine—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00976	CcSEcCtD
Lamivudine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00958	CcSEcCtD
Lamivudine—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00955	CcSEcCtD
Lamivudine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00946	CcSEcCtD
Lamivudine—NME1—nervous system—amyotrophic lateral sclerosis	0.00169	0.0141	CbGeAlD
Lamivudine—DCK—embryo—amyotrophic lateral sclerosis	0.00169	0.0141	CbGeAlD
Lamivudine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00931	CcSEcCtD
Lamivudine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00931	CcSEcCtD
Lamivudine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00167	0.0092	CcSEcCtD
Lamivudine—CMPK1—nervous system—amyotrophic lateral sclerosis	0.00163	0.0136	CbGeAlD
Lamivudine—NME1—central nervous system—amyotrophic lateral sclerosis	0.00163	0.0136	CbGeAlD
Lamivudine—Depression—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00885	CcSEcCtD
Lamivudine—NME2—nervous system—amyotrophic lateral sclerosis	0.00159	0.0133	CbGeAlD
Lamivudine—NME1—cerebellum—amyotrophic lateral sclerosis	0.00159	0.0133	CbGeAlD
Lamivudine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00158	0.0087	CcSEcCtD
Lamivudine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00866	CcSEcCtD
Lamivudine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00866	CcSEcCtD
Lamivudine—CMPK1—central nervous system—amyotrophic lateral sclerosis	0.00157	0.0131	CbGeAlD
Lamivudine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00851	CcSEcCtD
Lamivudine—CMPK1—cerebellum—amyotrophic lateral sclerosis	0.00153	0.0128	CbGeAlD
Lamivudine—NME2—central nervous system—amyotrophic lateral sclerosis	0.00153	0.0128	CbGeAlD
Lamivudine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0084	CcSEcCtD
Lamivudine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00838	CcSEcCtD
Lamivudine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00833	CcSEcCtD
Lamivudine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00829	CcSEcCtD
Lamivudine—NME2—cerebellum—amyotrophic lateral sclerosis	0.0015	0.0125	CbGeAlD
Lamivudine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00799	CcSEcCtD
Lamivudine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00797	CcSEcCtD
Lamivudine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00793	CcSEcCtD
Lamivudine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00791	CcSEcCtD
Lamivudine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00783	CcSEcCtD
Lamivudine—SLC22A3—embryo—amyotrophic lateral sclerosis	0.00138	0.0115	CbGeAlD
Lamivudine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00754	CcSEcCtD
Lamivudine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0013	0.0072	CcSEcCtD
Lamivudine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00718	CcSEcCtD
Lamivudine—Chills—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00715	CcSEcCtD
Lamivudine—NME1—brain—amyotrophic lateral sclerosis	0.00129	0.0108	CbGeAlD
Lamivudine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00704	CcSEcCtD
Lamivudine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00694	CcSEcCtD
Lamivudine—CMPK1—brain—amyotrophic lateral sclerosis	0.00124	0.0104	CbGeAlD
Lamivudine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00684	CcSEcCtD
Lamivudine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00681	CcSEcCtD
Lamivudine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0068	CcSEcCtD
Lamivudine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00674	CcSEcCtD
Lamivudine—NME2—brain—amyotrophic lateral sclerosis	0.00122	0.0102	CbGeAlD
Lamivudine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00671	CcSEcCtD
Lamivudine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00667	CcSEcCtD
Lamivudine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00118	0.0065	CcSEcCtD
Lamivudine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00644	CcSEcCtD
Lamivudine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00641	CcSEcCtD
Lamivudine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00634	CcSEcCtD
Lamivudine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00626	CcSEcCtD
Lamivudine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00623	CcSEcCtD
Lamivudine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00622	CcSEcCtD
Lamivudine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00621	CcSEcCtD
Lamivudine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00111	0.0061	CcSEcCtD
Lamivudine—Cough—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00606	CcSEcCtD
Lamivudine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00601	CcSEcCtD
Lamivudine—DCK—medulla oblongata—amyotrophic lateral sclerosis	0.00108	0.00904	CbGeAlD
Lamivudine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00591	CcSEcCtD
Lamivudine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00591	CcSEcCtD
Lamivudine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00591	CcSEcCtD
Lamivudine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00589	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00587	CcSEcCtD
Lamivudine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00584	CcSEcCtD
Lamivudine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00578	CcSEcCtD
Lamivudine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00571	CcSEcCtD
Lamivudine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00566	CcSEcCtD
Lamivudine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00566	CcSEcCtD
Lamivudine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00563	CcSEcCtD
Lamivudine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00557	CcSEcCtD
Lamivudine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00555	CcSEcCtD
Lamivudine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.001	0.00554	CcSEcCtD
Lamivudine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000997	0.0055	CcSEcCtD
Lamivudine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000992	0.00547	CcSEcCtD
Lamivudine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000978	0.0054	CcSEcCtD
Lamivudine—DCK—spinal cord—amyotrophic lateral sclerosis	0.000962	0.00806	CbGeAlD
Lamivudine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000959	0.00529	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000935	0.00516	CcSEcCtD
Lamivudine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000928	0.00512	CcSEcCtD
Lamivudine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000921	0.00509	CcSEcCtD
Lamivudine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000915	0.00505	CcSEcCtD
Lamivudine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000912	0.00503	CcSEcCtD
Lamivudine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000903	0.00499	CcSEcCtD
Lamivudine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000892	0.00492	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000886	0.00489	CcSEcCtD
Lamivudine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000885	0.00488	CcSEcCtD
Lamivudine—Pain—Riluzole—amyotrophic lateral sclerosis	0.000878	0.00484	CcSEcCtD
Lamivudine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000878	0.00484	CcSEcCtD
Lamivudine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000846	0.00467	CcSEcCtD
Lamivudine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000839	0.00463	CcSEcCtD
Lamivudine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000815	0.0045	CcSEcCtD
Lamivudine—SLC22A6—brain—amyotrophic lateral sclerosis	0.000812	0.0068	CbGeAlD
Lamivudine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000811	0.00448	CcSEcCtD
Lamivudine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000811	0.00448	CcSEcCtD
Lamivudine—DCK—nervous system—amyotrophic lateral sclerosis	0.000811	0.00679	CbGeAlD
Lamivudine—DCK—central nervous system—amyotrophic lateral sclerosis	0.000781	0.00654	CbGeAlD
Lamivudine—ABCC3—nervous system—amyotrophic lateral sclerosis	0.000776	0.0065	CbGeAlD
Lamivudine—DCK—cerebellum—amyotrophic lateral sclerosis	0.000763	0.00639	CbGeAlD
Lamivudine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000756	0.00417	CcSEcCtD
Lamivudine—ABCC3—central nervous system—amyotrophic lateral sclerosis	0.000748	0.00626	CbGeAlD
Lamivudine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000736	0.00406	CcSEcCtD
Lamivudine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000726	0.00401	CcSEcCtD
Lamivudine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000702	0.00387	CcSEcCtD
Lamivudine—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.000692	0.00579	CbGeAlD
Lamivudine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000679	0.00374	CcSEcCtD
Lamivudine—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.000666	0.00557	CbGeAlD
Lamivudine—SLC22A3—nervous system—amyotrophic lateral sclerosis	0.000661	0.00553	CbGeAlD
Lamivudine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000652	0.0036	CcSEcCtD
Lamivudine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000647	0.00357	CcSEcCtD
Lamivudine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000646	0.00357	CcSEcCtD
Lamivudine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000643	0.00355	CcSEcCtD
Lamivudine—ABCC4—nervous system—amyotrophic lateral sclerosis	0.000641	0.00537	CbGeAlD
Lamivudine—SLC22A3—central nervous system—amyotrophic lateral sclerosis	0.000636	0.00533	CbGeAlD
Lamivudine—DCK—brain—amyotrophic lateral sclerosis	0.00062	0.00519	CbGeAlD
Lamivudine—ABCC4—central nervous system—amyotrophic lateral sclerosis	0.000617	0.00517	CbGeAlD
Lamivudine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00061	0.00336	CcSEcCtD
Lamivudine—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000602	0.00504	CbGeAlD
Lamivudine—ABCC3—brain—amyotrophic lateral sclerosis	0.000593	0.00497	CbGeAlD
Lamivudine—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000537	0.00449	CbGeAlD
Lamivudine—SLC22A1—brain—amyotrophic lateral sclerosis	0.000529	0.00443	CbGeAlD
Lamivudine—ABCC1—cerebellum—amyotrophic lateral sclerosis	0.000514	0.0043	CbGeAlD
Lamivudine—SLC22A3—brain—amyotrophic lateral sclerosis	0.000505	0.00423	CbGeAlD
Lamivudine—ABCC4—brain—amyotrophic lateral sclerosis	0.00049	0.0041	CbGeAlD
Lamivudine—ABCB1—embryo—amyotrophic lateral sclerosis	0.000465	0.00389	CbGeAlD
Lamivudine—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000426	0.00356	CbGeAlD
Lamivudine—ABCC1—brain—amyotrophic lateral sclerosis	0.000418	0.0035	CbGeAlD
Lamivudine—ABCG2—brain—amyotrophic lateral sclerosis	0.000346	0.00289	CbGeAlD
Lamivudine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000297	0.00249	CbGeAlD
Lamivudine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000265	0.00222	CbGeAlD
Lamivudine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000223	0.00187	CbGeAlD
Lamivudine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000215	0.0018	CbGeAlD
Lamivudine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.00021	0.00176	CbGeAlD
Lamivudine—ABCB1—brain—amyotrophic lateral sclerosis	0.000171	0.00143	CbGeAlD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000153	0.000809	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000152	0.000803	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000152	0.000801	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000151	0.000801	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00015	0.000795	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00015	0.000793	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000149	0.000788	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000147	0.000779	CbGpPWpGaD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000147	0.000775	CbGpPWpGaD
Lamivudine—PGK1—Disease—CASP9—amyotrophic lateral sclerosis	0.000146	0.000773	CbGpPWpGaD
Lamivudine—ABCC2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000145	0.000768	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00014	0.000739	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000139	0.000738	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000139	0.000735	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000139	0.000733	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000139	0.000733	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000137	0.000727	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000137	0.000723	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000136	0.000719	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000135	0.000714	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000134	0.000709	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000134	0.000709	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000131	0.000695	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000131	0.000695	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000131	0.000695	CbGpPWpGaD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000131	0.000691	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00013	0.000686	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000129	0.000683	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000129	0.000683	CbGpPWpGaD
Lamivudine—NME1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000128	0.000679	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000128	0.000679	CbGpPWpGaD
Lamivudine—ABCG2—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000128	0.000677	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000127	0.000674	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000127	0.00067	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000127	0.00067	CbGpPWpGaD
Lamivudine—PGK1—Disease—ERBB4—amyotrophic lateral sclerosis	0.000125	0.000661	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000123	0.000653	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000123	0.000651	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000123	0.000651	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000123	0.000648	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000122	0.000644	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000121	0.000639	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000121	0.000639	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000121	0.000639	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000121	0.000639	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000119	0.000628	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000119	0.000628	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000119	0.000628	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000116	0.000615	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000116	0.000613	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TPK1—amyotrophic lateral sclerosis	0.000115	0.000609	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000115	0.000609	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000115	0.000607	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000114	0.000605	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000114	0.000603	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.000114	0.000602	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000114	0.000601	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000113	0.000596	CbGpPWpGaD
Lamivudine—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—amyotrophic lateral sclerosis	0.000113	0.000595	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000109	0.000578	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000109	0.000578	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000108	0.000573	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GSR—amyotrophic lateral sclerosis	0.000107	0.000567	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000107	0.000567	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000107	0.000567	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000106	0.00056	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000105	0.000556	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000105	0.000554	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000103	0.000543	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000103	0.000543	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000103	0.000543	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000102	0.000538	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000101	0.000532	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.96e-05	0.000527	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—APOE—amyotrophic lateral sclerosis	9.94e-05	0.000526	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—APOE—amyotrophic lateral sclerosis	9.94e-05	0.000526	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—APOE—amyotrophic lateral sclerosis	9.94e-05	0.000526	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—FIG4—amyotrophic lateral sclerosis	9.84e-05	0.000521	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.84e-05	0.000521	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	9.73e-05	0.000515	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	9.73e-05	0.000515	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—DAO—amyotrophic lateral sclerosis	9.69e-05	0.000512	CbGpPWpGaD
Lamivudine—PGK1—Disease—APOE—amyotrophic lateral sclerosis	9.67e-05	0.000512	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—VAPB—amyotrophic lateral sclerosis	9.65e-05	0.00051	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TPK1—amyotrophic lateral sclerosis	9.65e-05	0.00051	CbGpPWpGaD
Lamivudine—ABCC1—Disease—VTA1—amyotrophic lateral sclerosis	9.21e-05	0.000487	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.15e-05	0.000484	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	9.15e-05	0.000484	CbGpPWpGaD
Lamivudine—NME2—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.11e-05	0.000482	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	9.07e-05	0.00048	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9e-05	0.000476	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	8.94e-05	0.000473	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	8.94e-05	0.000473	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	8.92e-05	0.000472	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—DAO—amyotrophic lateral sclerosis	8.9e-05	0.000471	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.85e-05	0.000468	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—VAPA—amyotrophic lateral sclerosis	8.83e-05	0.000467	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CHAT—amyotrophic lateral sclerosis	8.81e-05	0.000466	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.76e-05	0.000463	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	8.66e-05	0.000458	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	8.66e-05	0.000458	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	8.65e-05	0.000458	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	8.55e-05	0.000453	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	8.55e-05	0.000453	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	8.49e-05	0.000449	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	8.49e-05	0.000449	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—VAPB—amyotrophic lateral sclerosis	8.4e-05	0.000444	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TPK1—amyotrophic lateral sclerosis	8.4e-05	0.000444	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.37e-05	0.000443	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.2e-05	0.000434	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.17e-05	0.000432	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	8.14e-05	0.000431	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—APOE—amyotrophic lateral sclerosis	8.1e-05	0.000428	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	7.96e-05	0.000421	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—VAPB—amyotrophic lateral sclerosis	7.83e-05	0.000414	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TPK1—amyotrophic lateral sclerosis	7.83e-05	0.000414	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	7.77e-05	0.000411	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	7.72e-05	0.000409	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	7.71e-05	0.000408	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—FIG4—amyotrophic lateral sclerosis	7.71e-05	0.000408	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—VAPA—amyotrophic lateral sclerosis	7.69e-05	0.000407	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	7.62e-05	0.000403	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—APOE—amyotrophic lateral sclerosis	7.53e-05	0.000398	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.53e-05	0.000398	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.53e-05	0.000398	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.45e-05	0.000394	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.45e-05	0.000394	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	7.43e-05	0.000393	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PLB1—amyotrophic lateral sclerosis	7.34e-05	0.000388	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.22e-05	0.000382	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—VAPA—amyotrophic lateral sclerosis	7.16e-05	0.000379	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.14e-05	0.000378	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CHMP2B—amyotrophic lateral sclerosis	6.98e-05	0.000369	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—DAO—amyotrophic lateral sclerosis	6.98e-05	0.000369	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.94e-05	0.000367	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.94e-05	0.000367	CbGpPWpGaD
Lamivudine—NME1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.9e-05	0.000365	CbGpPWpGaD
Lamivudine—NME2—Metabolism—APOE—amyotrophic lateral sclerosis	6.89e-05	0.000364	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.81e-05	0.00036	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.81e-05	0.00036	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.81e-05	0.00036	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	6.79e-05	0.000359	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GSR—amyotrophic lateral sclerosis	6.77e-05	0.000358	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PLB1—amyotrophic lateral sclerosis	6.75e-05	0.000357	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—FIG4—amyotrophic lateral sclerosis	6.72e-05	0.000355	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.71e-05	0.000355	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.66e-05	0.000352	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.64e-05	0.000351	CbGpPWpGaD
Lamivudine—PGK1—Disease—PTGS2—amyotrophic lateral sclerosis	6.63e-05	0.000351	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—SOD1—amyotrophic lateral sclerosis	6.53e-05	0.000345	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.34e-05	0.000336	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PLB1—amyotrophic lateral sclerosis	6.31e-05	0.000334	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	6.29e-05	0.000333	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—FIG4—amyotrophic lateral sclerosis	6.26e-05	0.000331	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSR—amyotrophic lateral sclerosis	6.23e-05	0.000329	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.19e-05	0.000327	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	6.14e-05	0.000325	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	6.08e-05	0.000321	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	5.86e-05	0.00031	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.67e-05	0.0003	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—DAO—amyotrophic lateral sclerosis	5.66e-05	0.0003	CbGpPWpGaD
Lamivudine—ABCC1—Disease—VCP—amyotrophic lateral sclerosis	5.63e-05	0.000298	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CHAT—amyotrophic lateral sclerosis	5.56e-05	0.000294	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.55e-05	0.000294	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	5.37e-05	0.000284	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	5.3e-05	0.000281	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PLB1—amyotrophic lateral sclerosis	5.29e-05	0.00028	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	5.26e-05	0.000278	CbGpPWpGaD
Lamivudine—NME1—Metabolism—APOE—amyotrophic lateral sclerosis	5.22e-05	0.000276	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.16e-05	0.000273	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CHAT—amyotrophic lateral sclerosis	5.11e-05	0.00027	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	5.06e-05	0.000268	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	5.05e-05	0.000267	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSR—amyotrophic lateral sclerosis	4.88e-05	0.000258	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.79e-05	0.000253	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.73e-05	0.00025	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.72e-05	0.00025	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.67e-05	0.000247	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	4.65e-05	0.000246	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	4.6e-05	0.000244	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.59e-05	0.000243	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.59e-05	0.000243	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	4.56e-05	0.000241	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.44e-05	0.000235	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.35e-05	0.00023	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	4.29e-05	0.000227	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.29e-05	0.000227	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	4.25e-05	0.000225	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.2e-05	0.000222	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.07e-05	0.000215	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.07e-05	0.000215	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CST3—amyotrophic lateral sclerosis	4.04e-05	0.000214	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.01e-05	0.000212	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	3.98e-05	0.000211	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	3.96e-05	0.000209	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.9e-05	0.000206	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.67e-05	0.000194	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.66e-05	0.000193	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.63e-05	0.000192	CbGpPWpGaD
Lamivudine—DCK—Metabolism—APOE—amyotrophic lateral sclerosis	3.58e-05	0.000189	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.58e-05	0.000189	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.53e-05	0.000186	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.49e-05	0.000185	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	3.44e-05	0.000182	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	3.32e-05	0.000176	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.25e-05	0.000172	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.2e-05	0.000169	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.99e-05	0.000158	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CASP9—amyotrophic lateral sclerosis	2.94e-05	0.000155	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	2.85e-05	0.000151	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.75e-05	0.000145	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.75e-05	0.000145	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.65e-05	0.00014	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.6e-05	0.000138	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.53e-05	0.000134	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.52e-05	0.000133	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB4—amyotrophic lateral sclerosis	2.51e-05	0.000133	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.51e-05	0.000133	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.45e-05	0.00013	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	2.32e-05	0.000123	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—APOE—amyotrophic lateral sclerosis	2.26e-05	0.00012	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	2.25e-05	0.000119	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.15e-05	0.000114	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—APOE—amyotrophic lateral sclerosis	2.08e-05	0.00011	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.98e-05	0.000105	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	1.97e-05	0.000104	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APOE—amyotrophic lateral sclerosis	1.94e-05	0.000103	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.91e-05	0.000101	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.89e-05	0.0001	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.88e-05	9.92e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.75e-05	9.25e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.74e-05	9.21e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.72e-05	9.12e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.7e-05	8.99e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—APOE—amyotrophic lateral sclerosis	1.63e-05	8.61e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.61e-05	8.5e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.55e-05	8.19e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	1.43e-05	7.58e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.42e-05	7.53e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.42e-05	7.5e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—amyotrophic lateral sclerosis	1.33e-05	7.05e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.32e-05	6.99e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.12e-05	5.9e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.02e-05	5.42e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.82e-06	5.19e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.72e-06	5.14e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.41e-06	4.98e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.06e-06	4.79e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	7.75e-06	4.1e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.31e-06	2.81e-05	CbGpPWpGaD
